Quantum Genomics Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • ALQGC
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.34
  • (As of Thursday Closing)

Quantum Genomics General Information

Description

Quantum Genomics is a biopharmaceutical company engaged in developing new products for unmet needs in the field of cardiovascular diseases, high blood pressure, and heart failure. The company products include QGC001, QGC006, QGC011, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
PAR
Primary Office
  • 33 rue Marbeuf
  • 75008 Paris
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quantum Genomics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.34 $4.53 $2.57 - $6.87 $116M 26.8M 314K -$0.49

Quantum Genomics Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 148,559 148,559 51,698 63,677
Revenue 1,372 1,372 0 0
EBITDA (15,795) (15,795) (12,032) (15,914)
Net Income (13,151) (13,151) (10,163) (14,149)
Total Assets 42,990 42,990 16,922 21,140
Total Debt 2 2 2 3
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Quantum Genomics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Quantum Genomics‘s full profile, request access.

Request a free trial

Quantum Genomics Executive Team (7)

Name Title Board Seat Contact Info
Jean-Philippe Milon Ph.D Chief Executive Officer
Lionel Ségard Chairman & President
Maurice Salama Board Member & Managing Director of International Multifinance
Benoit Gueugnon Administrative and Financial Director
Bruno Besse Chief Medical Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Quantum Genomics Board Members (4)

Name Representing Role Since
000000000 0é0000 Self Board Member 000 0000
000000 0é0000 Quantum Genomics Chairman & President 000 0000
0000000 000000 Quantum Genomics Board Member & Managing Director of International Multifinance 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Quantum Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quantum Genomics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Quantum Genomics‘s full profile, request access.

Request a free trial

Quantum Genomics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 29-Oct-2007 000000000000000000 Consulting Services (B2B) 000000 0é0000
To view Quantum Genomics’s complete acquisitions history, request access »

Quantum Genomics Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 29-Oct-2007 000000000000000000 Completed
  • 0000000 00000000
To view Quantum Genomics’s complete exits history, request access »